Malin Corporation
Malin Corporation plc is an Irish public limited company established in 2015, with its headquarters in Dublin and additional offices in New Haven, Connecticut, and Research Triangle, North Carolina. The company specializes in venture capital investments, focusing on innovative enterprises within the life sciences and healthcare technology sectors, particularly in oncology, immunology, and genetic diseases. Malin's strategy involves the selective application of capital and operational expertise to support private, pre-IPO, and pre-trade sale businesses in rapidly growing markets. By actively engaging with its investee companies, Malin aims to enhance their value propositions and facilitate their journey toward commercial success.
Artizan Biosciences
Venture Round in 2017
Artizan Biosciences, Inc. is a biotechnology company based in New Haven, Connecticut, founded in 2016. The company focuses on developing small molecule drugs aimed at treating serious diseases linked to intestinal inflammation. Utilizing its proprietary IgA-SEQ technology platform, Artizan distinguishes disease-driving bacteria within the intestinal microbiota. This innovative approach enables the development of precision therapeutics designed to address unmet medical needs in various conditions, including digestive disorders, obesity, autoimmune diseases, and disorders affecting the skin, lungs, and central nervous system. Through its research, Artizan aims to provide new and potentially curative treatment options for patients suffering from these diverse health challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.